SALTROL

This brand name is authorized in Nigeria.

Active ingredients

The drug SALTROL contains a combination of these active pharmaceutical ingredients (APIs):

1
UNII O2GMZ0LF5W - FLUTICASONE PROPIONATE
 

Fluticasone has anti-inflammatory and vasoconstrictive features. Fluticasone given by inhalation at recommended doses has a potent glucocorticoid anti-inflammatory action within the lungs, resulting in a reduction of both symptoms and exacerbations of asthma, with a lower incidence and severity of adverse effects than those observed when corticosteroids are administered systemically.

 
Read more about Fluticasone
2
UNII 6EW8Q962A5 - SALMETEROL XINAFOATE
 

Salmeterol is a selective long-acting (12 hour) β2 adrenoceptor agonist. These pharmacological properties of salmeterol offer more effective protection against histamine-induced bronchoconstriction and produce a longer duration of bronchodilation, lasting for at least 12 hours, than recommended doses of conventional short-acting β2 agonists.

 
Read more about Salmeterol

Packages

This drug has been approved in Nigeria as follows:

Identifier Form Presentation Description Approval
B4-9409 Pressurised inhalation SALTROL INHALER 25MCG + 125MCG INHALANT 125 mcg; 25 mcg 1 X 120 18 RNW-PP-339252 SALTROL INHALER 25MCG + 125MCG SALMETEROL 25MCG + FLUTICASONE PROPIONATE 125MCG SALMETERO 25MCG, FLUTICASONE PROPIONATE PH. EUR. 125MCG ALSO CONTAINS: CFC-FREE PROPELLANT, HFA 134A B4-9409 Drugs Imported Products 1120 POM 1 7/11/2023 GETZ PHARMA NIGERIA LIMITED, PLOT 2, IJAODOLA CLOSE, OFF ADEYEMO ALAKIJA STREET, IKEJA GRA, LAGOS. 8165370750 nneka.obegolu@getzpharma.com GETZ PHARMA (PRIVATE) LIMITED, 29 – 30/27, KORANGI INDUSTRIAL AREA,KARACHI-74900 PAKISTAN , Pakistan 31/10/2023
B4-9595 Spray, Metered-Dose SALTROL INHALER 25MCG + 250MCG SPRAY_MET 250 mcg/Metered-Dose; 25 mcg/Metered-Dose 1 X 120 128 RNW-PP-354550 SALTROL INHALER 25MCG + 250MCG SALMETEROL 25MCG + FLUTICASONE PROPIONATE 250MCG SALMETERO 25MCG, FLUTICASONE PROPIONATE PH. EUR. 250MCG ALSO CONTAINS: CFC-FREE PROPELLANT, HFA 134A B4-9595 Drugs Imported Products 1120 POM 1 9/26/2023 GETZ PHARMA NIGERIA LIMITED, PLOT 2, IJAODOLA CLOSE, OFF ADEYEMO ALAKIJA STREET, IKEJA GRA, LAGOS. 8165370750 nneka.obegolu@getzpharma.com GETZ PHARMA (PRIVATE) LIMITED, 29 – 30/27, KORANGI INDUSTRIAL AREA,KARACHI-74900 PAKISTAN , Pakistan 21/12/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
R03AK06 Salmeterol and fluticasone R Respiratory system → R03 Drugs for obstructive airway diseases → R03A Adrenergics, inhalants → R03AK Adrenergics and other drugs for obstructive airway diseases
Discover more medicines within R03AK06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
NG Registered Drug Product Database B4-9409, B4-9595

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.